Toronto, Canada

Dzana Dervovic

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignee: University Health Network. Active years: 2022-2026.


% Patents Active = 50.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dzana Dervovic: Innovator in Regulatory T Cell Expansion

Introduction

Dzana Dervovic is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of immunology, particularly in the expansion of regulatory T cells. Her innovative work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Dzana holds a patent for a method titled "Method for expansion of double negative regulatory T cells." This patent describes a technique for expanding human CD4-CD8- regulatory T cells (DN Tregs) from a population of cells. The method involves culturing the population of cells with artificial antigen presenting cells (APCs). This advancement is crucial for enhancing the efficacy of DN Tregs in therapeutic applications.

Career Highlights

Dzana Dervovic is affiliated with the University Health Network, where she conducts her research. Her work focuses on the manipulation and expansion of T cells, which are vital for immune regulation. Dzana's research is paving the way for new treatments in immunotherapy.

Collaborations

Dzana collaborates with esteemed colleagues, including Paulina Achita and Jong Bok Lee. These partnerships enhance the research environment and contribute to the advancement of their shared goals in immunology.

Conclusion

Dzana Dervovic is a pioneering inventor whose work in expanding regulatory T cells holds promise for future medical advancements. Her contributions to the field are noteworthy and reflect her commitment to improving therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…